Vinehealth, offering digital support for cancer patients and SaaS for R&D, gets $5.5M to launch in the US

We are so thrilled to announce that Vinehealth has raised $5.5 million of investment in our latest seed funding round, led by Talis Capital with participation from previous investors Playfair Capital and Ascension, as well as a number of angel investors. 

This investment builds on our CE mark which was achieved in record time earlier this year; a significant regulatory milestone and will help us to further develop our product, scale our team and expand in the US.

For more information about our fundraise and interview with Tech Crunch see here.